In the present study, we observed a much more severe development of CIA in C57BL/6 mice deficient in CD163 expression compared to wild-type C57BL/6 mice that have a genetic background characterized by a general low susceptibility to collagen immunization in terms of arthritis development. The gene discussed is CD163; the disease is arthritic joint disease.